Placental site trophoblastic tumor

From WikiProjectMed
Jump to navigation Jump to search
Placental site trophoblastic tumor
Photomicrograph showing proliferating intermediate trophoblast with scarce cytotophoblastic and syncytiotrophoblastic elements
SpecialtyOncology, obstetrics

Placental site trophoblastic tumor is a form of gestational trophoblastic disease, which is thought to arise from intermediate trophoblast.[1]

The tumor may secrete human placental lactogen,[2] and result in a false-positive pregnancy test.[3]

A placental site trophoblastic tumor is a monophasic neoplasm of the implantation site intermediate trophoblast, and usually a benign lesion, which comprises less than 2% of all gestational trophoblastic proliferations. Preceding conditions include molar pregnancy (5%). Compared to choriocarcinoma or invasive mole, hemorrhage is less conspicuous and serum β-HCG level is low, making early diagnosis difficult.

Immunohistochemistry: Often stains with hPL, keratin, Mel-CAM, EGFR.

Treatment

Because chemotherapy is ineffective; the patient should undergo hysterectomy.

Prognosis

10–20% of cases metastasize leading to death.

References

  1. ^ Shih IM, Kurman RJ (January 2001). "The pathology of intermediate trophoblastic tumors and tumor-like lesions". International Journal of Gynecological Pathology. 20 (1): 31–47. doi:10.1097/00004347-200101000-00004. PMID 11192071.
  2. ^ "Question 1". Examinations in Organ System Pathology. Archived from the original on 6 April 2010.
  3. ^ Whitney KA (December 2009). "Placental site trophoblastic tumor". The American Journal of Nursing. 109 (12): 32–7, quiz 38. doi:10.1097/01.NAJ.0000365176.62954.11. PMID 19935163. S2CID 5535092.

External links